Q waves to guide treatment of myocardial infarction

Lancet

Volumn 367, Issue 9528, 2006, Pages 2035-2037

  Cooper, Howard ^a   Panza, Julio A ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; STREPTOKINASE;

ARTICLE; BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE MARKER; ECG ABNORMALITY; EPIDEMIOLOGICAL DATA; FIBRINOLYTIC THERAPY; HEART DEATH; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART REINFARCTION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RECANALIZATION; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; TREATMENT INDICATION;

EID: 33745221910     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68899-5     Document Type: Note

References (14)

1. Hasdai D., Behar S., Wallentin L., et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 23 (2002) 1190-1201
2. Rogers W., Bowlby L., Chandra N., et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 90 (1994) 2103-2114
3. Rogers W., Canto J., Lambrew C., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 36 (2000) 2056-2063
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
5. Keeley E., Boura J., and Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
6. Dalby M., Bouzamondo A., Lechat P., and Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 108 (2003) 1809-1814
7. Antman E., Anbe D., Armstrong P., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) E1-211
8. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24 (2003) 28-66
9. Hochman J., Sleeper L., Webb J., and for the SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341 (1999) 625-634
10. Wu A., Parsons L., Every N., and Bates E. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 40 (2002) 1389-1394
11. Wong C.-K., Gao W., Raffel O., and for the HERO-2 Investigators. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. Lancet 367 (2006) 2061-2067
12. White H., and Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 358 (2001) 1855-1863
13. Reimer K., Jennings R., Cobb F., et al. Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. Circ Res 56 (1985) 651-665
14. Nallamothu B., Bates E., Wang Y., Bradley E., and Krumholz H. Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation 113 (2006) 1189-1195